tiprankstipranks
Advertisement
Advertisement

KURA Stock Latest News

Kura Oncology: Early Darlifarnib Kidney Cancer Data Validate FTI Strategy and Underscore Attractive Risk‑Reward Upside
RatingsKura Oncology: Early Darlifarnib Kidney Cancer Data Validate FTI Strategy and Underscore Attractive Risk‑Reward Upside
15d ago
KURA
Kura Oncology: Compelling Darlifarnib–Cabozantinib Data in Post-IO RCC Support Continued Buy Rating
PremiumRatings
Kura Oncology: Compelling Darlifarnib–Cabozantinib Data in Post-IO RCC Support Continued Buy Rating
18d ago
KURA
Kura Oncology reports results from ongoing FIT-001 clinical trial
PremiumThe Fly
Kura Oncology reports results from ongoing FIT-001 clinical trial
18d ago
KURA
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
PremiumMarket News
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 4/16/2026
19d ago
ANGX
IMRX
Kura Oncology initiated with a Buy at Lake Street
PremiumThe Fly
Kura Oncology initiated with a Buy at Lake Street
21d ago
KURA
Syndax assumed with a Buy at Jefferies
PremiumThe FlySyndax assumed with a Buy at Jefferies
1M ago
KURA
SNDX
Kura Oncology price target lowered to $25 from $30 at Mizuho
Premium
The Fly
Kura Oncology price target lowered to $25 from $30 at Mizuho
1M ago
KURA
Kura Oncology price target lowered to $15 from $16 at UBS
Premium
The Fly
Kura Oncology price target lowered to $15 from $16 at UBS
2M ago
KURA
Kura Oncology price target raised to $30 from $29 at BofA
PremiumThe Fly
Kura Oncology price target raised to $30 from $29 at BofA
2M ago
KURA
Kura Oncology price target lowered to $36 from $38 at Wedbush
PremiumThe Fly
Kura Oncology price target lowered to $36 from $38 at Wedbush
2M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
2M ago
KURA
Kura Oncology Earnings Call Highlights Comzifty Launch
PremiumCompany Announcements
Kura Oncology Earnings Call Highlights Comzifty Launch
2M ago
KURA
Early Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
PremiumRatingsEarly Komzifti Traction and Clinical Catalysts Underpin Buy Rating and 2028 Growth Outlook
2M ago
KURA
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
Premium
Ratings
Kura Oncology: Early KOMZIFTI Launch Momentum, Robust AML Data, and Strong Cash Runway Underpin Buy Rating
2M ago
KURA
Kura Oncology reports Q4 EPS (92c), consensus (49c)
Premium
The Fly
Kura Oncology reports Q4 EPS (92c), consensus (49c)
2M ago
KURA
Kura Oncology management to meet with Citizens
PremiumThe Fly
Kura Oncology management to meet with Citizens
2M ago
KURA
KURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KURA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
3M ago
KURA
Kura Oncology price target lowered to $29 from $30 at BofA
PremiumThe Fly
Kura Oncology price target lowered to $29 from $30 at BofA
3M ago
KURA
Kura Oncology Tightens Governance with Amended Bylaws
PremiumCompany AnnouncementsKura Oncology Tightens Governance with Amended Bylaws
3M ago
8K
KURA
3 ‘Strong Buy’ Biotech Stocks to Buy Today, 1/13/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Today, 1/13/2026, According to Top Analysts
4M ago
WVE
KURA
Kura Oncology price target lowered to $20 from $25 at Leerink
Premium
The Fly
Kura Oncology price target lowered to $20 from $25 at Leerink
4M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >